- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/06 - 1,2,3-ThiadiazolesHydrogenated 1,2,3-thiadiazoles
Patent holdings for IPC class C07D 285/06
Total number of patents in this class: 114
10-year publication summary
|
15
|
5
|
12
|
6
|
11
|
3
|
6
|
3
|
3
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corteva Agriscience LLC | 2669 |
9 |
| Blade Therapeutics, Inc. | 19 |
7 |
| Bristol-myers Squibb Company | 4898 |
6 |
| Bayer Cropscience AG | 2035 |
4 |
| Abbvie Inc. | 1800 |
4 |
| Takeda Pharmaceutical Company Limited | 2713 |
4 |
| Calico Life Sciences LLC | 96 |
4 |
| Syngenta Participations AG | 1903 |
3 |
| Dow AgroSciences LLC | 1223 |
3 |
| Incyte Corporation | 1024 |
3 |
| Roche Palo Alto LLC | 74 |
3 |
| F. Hoffmann-La Roche AG | 7925 |
2 |
| Biotechnologijos Institutas | 5 |
2 |
| Epizyme, Inc. | 370 |
2 |
| Ligand Pharmaceuticals Incorporated | 169 |
2 |
| Ustav Experimentalni Botaniky AV CR, V.v.i. | 11 |
2 |
| Sanofi | 4055 |
2 |
| Genentech, Inc. | 3976 |
1 |
| Merck Patent GmbH | 5831 |
1 |
| Abbott Laboratories | 2399 |
1 |
| Other owners | 49 |